David E. Anderson
18Patents
3h-index
18Co-inventors
53Inventor score
Filing activity: Feb 28, 2006 → Feb 11, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9777043B2 | Compositions and methods for treatment of cytomegalovirus | Chemistry; Metallurgy | 10 | Active |
| US9610248B2 | Compositions and methods for treating influenza | Chemistry; Metallurgy | 6 | Active |
| US9849173B2 | Methods for preparing vesicles and formulations produced therefrom | Emerging Cross-Sectional Technologies | 4 | Active |
| US9603920B2 | Compositions and methods for treating influenza | Chemistry; Metallurgy | 3 | Active |
| US9907746B2 | Methods for preparing vesicles and formulations produced therefrom | Emerging Cross-Sectional Technologies | 2 | Active |
| US8029797B2 | Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions | Human Necessities | 2 | Active |
| US10736844B2 | Compositions and methods for treating viral infections | Emerging Cross-Sectional Technologies | 2 | Active |
| US11248026B2 | Compositions and methods for treatment of cytomegalovirus | Chemistry; Metallurgy | 1 | Active |
| US9833505B1 | Vaccine compositions for treatment of Zika virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US10161010B2 | Methods for detection of anti-cytomegalovirus neutralizing antibodies | Physics | 0 | Active |
| US11253587B2 | Vaccine compositions for the treatment of coronavirus | Chemistry; Metallurgy | 0 | Active |
| US10006096B2 | Methods for detection of anti-cytomegalovirus neutralizing antibodies | Physics | 0 | Active |
| US10456460B2 | Vaccine compositions for treatment of Zika virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US11167032B2 | Methods and compositions for therapeutic agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US12128100B2 | Immunogenic compositions for treatment of Hepatitis B | Chemistry; Metallurgy | 0 | Active |
| US9732320B2 | Selective differentiation, identification, and modulation of human TH17 cells | Chemistry; Metallurgy | 0 | Active |
| US12421283B2 | Compositions and methods for treatment of cytomegalovirus | Chemistry; Metallurgy | 0 | Active |
| US11167033B2 | Compositions and methods for treating viral infections | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.